Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Tags:
Vivus, Peregrine Pharmaceuticals, JNJ, Cellceutix
J&J Diabetes Pill May Have Heart Risks, FDA Staff Says
Bloomberg
Tue, 01/8/13 - 09:01 am
Tags:
FDA, diabetes, JNJ, Invokana
Sanofi Buys Rolaids, Plans Product Relaunch in 2013
Motley Fool
Mon, 01/7/13 - 06:53 pm
Tags:
Rolaids, Sanofi, M&A, OTC, antacids, JNJ
Big News for These 2 Diabetes Hopefuls
Motley Fool
Mon, 01/7/13 - 06:52 pm
Tags:
diabetes, empagliflozin, Eli Lilly, Invokana, JNJ
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
Tags:
JNJ, Invokana, SLGT-2 inhibitors, diabetes, Forxiga, Bristol-Myers Squibb, Pfizer, Raptor Pharmaceuticals
J&J Faces First Vaginal Mesh Implant Trial in New Jersey
Bloomberg
Mon, 01/7/13 - 10:21 am
Tags:
JNJ, vaginal mesh
Abbott, J&J, Sanofi Said to Show Bausch & Lomb Interest
Bloomberg
Fri, 01/4/13 - 09:53 am
Tags:
Abbott Labs, JNJ, Sanofi, Bausch & Lomb, M&A
What 2013 Has in Store for Johnson & Johnson
Motley Fool
Wed, 01/2/13 - 11:45 am
Tags:
JNJ
Top Alzheimer's Missteps of 2012
Motley Fool
Mon, 12/31/12 - 11:14 am
Tags:
Alzheimer's disease, Medivation, Pfizer, Eli Lilly, JNJ, Merck
J&J Sirturo Wins FDA Approval to Treat Drug-Resistant TB
Bloomberg
Mon, 12/31/12 - 10:32 am
Tags:
JNJ, Sirturo, FDA, tuberculosis
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
Tags:
HCV, Vertex Pharmaceuticals, Merck, Gilead Sciences, Abbott Laboratories, hepatitis C, Achillion, Idenix, JNJ, GSK
Is Johnson and Johnson Still a Safe Play?
Wall St Cheat Street
Sat, 12/29/12 - 10:28 am
Tags:
JNJ
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
Tags:
hepatitis C, Vertex Pharmaceuticals, Gilead, Merck, Abbott Labs, Achillion, GSK, JNJ, Idenix, Bristol-Myers Squibb
Will FDA Grant Accelerated Approval To J&J TB Drug?
Pharmalot
Fri, 12/28/12 - 11:33 am
Tags:
FDA, JNJ, tuberculosis, bedaquiline
Pfizer Playing the Right Card Amid Changing Sector Landscape
Motley Fool
Fri, 12/28/12 - 11:31 am
Tags:
Pfizer, Merck, JNJ
J&J Declines to Comment on U.S. Approval of Sanofi Deal
Bloomberg
Thu, 12/27/12 - 10:09 pm
Tags:
JNJ, Sanofi, antitrust
The 1 Biotech Event You Can't Miss This Week
Motley Fool
Sun, 12/23/12 - 05:24 pm
Tags:
JNJ, bedaquiline, tuberculosis
The Worst Could Be Over for J&J
WSJ Online
Sun, 12/23/12 - 10:03 am
Tags:
JNJ
Why Berkshire Soured on Johnson & Johnson
Motley Fool
Sat, 12/22/12 - 12:36 pm
Tags:
JNJ
Analyst Roundtable: Big Pharma Spinoffs
Motley Fool
Wed, 12/19/12 - 11:11 am
Tags:
Abbott Labs, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.